Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Personal Genome Sequencing - Not Worth It Yet

MP3 WAV

  • When the human genome was first sequenced, it took ten years and three billion dollars. Since then, the cost has fallen to a few thousand dollars, and companies will soon do it for less than a grand. So, anyone can mail out a tissue sample and in return, get a USB drive with their DNA sequence. But is it really worth it?

    One of the great promises of this technology is that one day, doctors will routinely practice personalized medicine ' to identify a person's susceptibility to developing disease, how that disease will progress, and how the person will respond to different types of treatment. Certain genetic disorders are easily predictable, based on the inheritance of a few genetic variances.

    For example, inheriting two hemoglobin genetic mutations can cause sickle cell disease. Other examples include muscular dystrophy, hemophilia and Huntington's disease which are among an estimated 4,000 single gene disorders. Genome sequencing will likely identify more of these simple genetic disorders involving one or a few genes.

    However, the vast majority of diseases are much more complex, and involve multiple genes and how they influence disease development. As a result, the potential of genome sequencing will be limited until scientists are better able to understand how disease develops.

    But even when a genetic test clears someone of a susceptibility to developing certain disease, it's not a free pass because the environment and lifestyle are critical factors. It means their risk is equal to the general population.

    While genome sequencing is becoming affordable, there's little a person can do with the information for now. Also, consider how such private information could be misused by insurance companies or potential employers. Always ask about a company's privacy policy before deciding to plunk down the money for a test.

More Information

Identical Twins Usually Don't Die From the Same Thing: The Lost Message About Genes & Disease
From Discover Magazine: "One of the great hopes for genetic medicine is that we will be able to predict which people will develop certain diseases, and then focus preventative measures to those at risk. Scientists have long known that one of the wrinkles in this plan is that we will only rarely be able to say with certainty whether someone develop a given disease based on their genetics'more often, we can only give an estimate of their disease risk."

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances
From the New York Times: "Complete Genomics, based in Mountain View, is one of more than three dozen firms hastening to push the cost of sequencing an entire human genome below $1,000. The challenge is part biology, part chemistry, part computing, and in Complete Genomics' case, part computer networking."

Cracking the Code of Life [Video]
Program Description from PBS: This two-hour special, hosted by ABC "Nightline" correspondent Robert Krulwich, chronicles the fiercely competitive race to capture one of the biggest scientific prizes ever: the complete letter-by-letter sequence of genetic information that defines human life'the human genome. NOVA tells the story of the genome triumph and its profound implications for medicine and human health.

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.